Streetbeat News

Equity Actions

CMND

Clearmind Medicine Inc (NASDAQ:CMND) announced the pricing of a $2.25 million public offering, causing its shares to drop by 53% to $0.18. The offering is expected to close on September 18. The company plans to use the proceeds for general corporate purposes, including R&D, working capital, future acquisitions, and capital expenditures.

Portfolio Pulse from Henry Khederian

September 14, 2023 | 3:03 pm

RYZB

RayzeBio, Inc (NASDAQ:RYZB) is set to IPO on September 15 on the NASDAQ exchange under the ticker RYZB. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024. RayzeBio is a vertically integrated radiopharmaceutical therapeutics company with a lead program in a Phase 3 clinical trial.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:00 pm

NMRA

Neumora Therapeutics, Inc (NASDAQ:NMRA) is set to IPO on September 15 on the NASDAQ exchange under the ticker NMRA. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 3:00 pm

ARM

Arm Holdings is indicating a price of $58 for its upcoming IPO, which is higher than the initial pricing of $52.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 2:53 pm

FWBI

First Wave BioPharma has announced the exercise of warrants and issuance of new warrants in a private placement for $4M, priced at $0.43 per share.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 2:46 pm

DB

Deutsche Bank (NYSE:DB) has announced a partnership with Swiss startup Taurus to offer global crypto custody services. The bank will use Taurus' technology to manage cryptocurrencies, tokenized assets, and digital assets. This follows Deutsche Bank's investment in Taurus as part of a $65 million Series B funding round led by Credit Suisse. The bank has been interested in offering cryptocurrency custody and trading services to its clients for the past three years.

Portfolio Pulse from Khyathi Dalal

September 14, 2023 | 2:40 pm

CMND

Clearmind announced the pricing of a $2.25 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 2:24 pm

BIOL

BIOLASE Inc announced the pricing of a $4.5 million underwritten public offering of Series J Convertible Redeemable Preferred Stock and warrants, causing its shares to drop by 38%. The proceeds will be used for working capital and general corporate purposes. Lake Street Capital Markets and Maxim Group are acting as joint bookrunners for the offering.

Portfolio Pulse from Henry Khederian

September 14, 2023 | 2:20 pm

BIOL

CMND

FWBI

PFSW

SEZL

UPTD

US stocks traded higher following the release of PPI data, with the Dow, NASDAQ, and S&P 500 all seeing gains. Energy shares jumped by 1.4%, while consumer discretionary shares fell by 0.1%. US producer prices rose by 0.7% in August 2023, higher than the expected 0.4% increase. Shares of First Wave BioPharma, PFSweb, and TradeUP Acquisition Corp. saw significant increases, while shares of Sezzle, Clearmind Medicine, and BIOLASE fell sharply.

Portfolio Pulse from Lisa Levin

September 14, 2023 | 2:03 pm

GENI

Genius Sports has announced the pricing of a secondary offering of 20 million shares at $5.35 per share by a selling shareholder.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 2:01 pm